These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27385318)

  • 21. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort.
    Mousa A; Naderpoor N; de Courten MPJ; Scragg R; de Courten B
    J Steroid Biochem Mol Biol; 2017 Oct; 173():258-264. PubMed ID: 28007531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory markers and cardiometabolic diseases.
    Esser N; Paquot N; Scheen AJ
    Acta Clin Belg; 2015 Jun; 70(3):193-9. PubMed ID: 26103538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic analysis of mature adipocytes from obese patients in relation to aging.
    Alfadda AA; Benabdelkamel H; Masood A; Moustafa A; Sallam R; Bassas A; Duncan M
    Exp Gerontol; 2013 Nov; 48(11):1196-203. PubMed ID: 23886751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing cardiometabolic risk: an evolving approach to patient care.
    Watson K
    Crit Pathw Cardiol; 2007 Mar; 6(1):5-14. PubMed ID: 17667880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of secreted proteins associated with obesity and type 2 diabetes in Psammomys obesus.
    Bolton K; Segal D; McMillan J; Sanigorski A; Collier G; Walder K
    Int J Obes (Lond); 2009 Oct; 33(10):1153-65. PubMed ID: 19636319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complement system in human cardiometabolic disease.
    Hertle E; Stehouwer CD; van Greevenbroek MM
    Mol Immunol; 2014 Oct; 61(2):135-48. PubMed ID: 25017306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metallothionein 2a gene expression is increased in subcutaneous adipose tissue of type 2 diabetic patients.
    Haynes V; Connor T; Tchernof A; Vidal H; Dubois S
    Mol Genet Metab; 2013 Jan; 108(1):90-4. PubMed ID: 23148893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity.
    Li Z; Picard F
    Horm Metab Res; 2010 Oct; 42(11):787-91. PubMed ID: 20730703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes.
    Song YS; Lee SK; Jang YJ; Park HS; Kim JH; Lee YJ; Heo YS
    Diabetes Res Clin Pract; 2013 Sep; 101(3):341-8. PubMed ID: 23876548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
    Goncalves I; Bengtsson E; Colhoun HM; Shore AC; Palombo C; Natali A; Edsfeldt A; Dunér P; Fredrikson GN; Björkbacka H; Östling G; Aizawa K; Casanova F; Persson M; Gooding K; Strain D; Khan F; Looker HC; Adams F; Belch J; Pinnoli S; Venturi E; Kozakova M; Gan LM; Schnecke V; Nilsson J;
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1723-31. PubMed ID: 25953645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women.
    Elffers TW; de Mutsert R; Lamb HJ; de Roos A; Willems van Dijk K; Rosendaal FR; Jukema JW; Trompet S
    PLoS One; 2017; 12(9):e0185403. PubMed ID: 28957363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation.
    Catalán V; Gómez-Ambrosi J; Rodríguez A; Silva C; Rotellar F; Gil MJ; Cienfuegos JA; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):213-9. PubMed ID: 17803693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral adiposopathy: a vascular perspective.
    Farb MG; Gokce N
    Horm Mol Biol Clin Investig; 2015 Feb; 21(2):125-36. PubMed ID: 25781557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction.
    Laforest S; Labrecque J; Michaud A; Cianflone K; Tchernof A
    Crit Rev Clin Lab Sci; 2015; 52(6):301-13. PubMed ID: 26292076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abdominal obesity as important component of insulin-resistance syndrome.
    Després JP
    Nutrition; 1993; 9(5):452-9. PubMed ID: 8286886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.